Showing results (691-700 of 739) with videos related to
Sort By:
Pageof 74
International Journal of Cancer|April 28, 2005
Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese populationLi-Na Mu, Qing-Yi Lu, Shun-Zhang Yu, et al.Plos One|August 1, 2012
Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populationsMei-Ling Zhu, Ting-Yan Shi, Hai-Chuan Hu, et al.Cancer Epidemiology|February 15, 2011
Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese populationYanli Li, Shen-Chih Chang, Binh Y Goldstein, et al.Nature Communications|February 11, 2025
Advancing Ag<sub>2</sub>Se thin-film thermoelectrics via selenization-driven anisotropy controlTianyi Cao, Xiao-Lei Shi, Boxuan Hu, et al.Frontiers in Veterinary Science|April 3, 2023
Detection of antibiotic-resistant canine origin <i>Escherichia coli</i> and the synergistic effect of magnolol in reducing the resistance of multidrug-resistant <i>Escherichia coli</i>Yin-Chao Tong, Yi-Ning Zhang, Peng-Cheng Li, et al.Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|October 10, 2006
The association of polymorphisms of CDT1 and GMNN gene with the risk of breast cancer in Chinese women: a case-control analysisJun Gao, Hong-xia Ma, Yan Zhou, et al.Oncotarget|October 21, 2015
Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese populationLi-Xin Qiu, Jing He, Lei Cheng, et al.International Journal of Molecular Sciences|June 10, 2023
Detection of Antibiotic Resistance in Feline-Origin ESBL <i>Escherichia coli</i> from Different Areas of China and the Resistance Elimination of Garlic Oil to Cefquinome on ESBL <i>E. coli</i>Yin-Chao Tong, Peng-Cheng Li, Yang Yang, et al.Bioactive Materials|April 25, 2025
All-in-one extracellular matrix-based powders with instant self-assembly and multiple bioactivities integrate hemostasis and in-situ tissue functional repairChen-Yu Zou, Chen Han, Ming Xiong, et al.Cell Death & Disease|February 11, 2022
ALCAM regulates multiple myeloma chemoresistant side populationFangfang Wang, Zhang Dan, Hongmei Luo, et al.Pageof 74